Compare $DYAI vs $MRKR | Chartloom

Compare

$DYAI vs $MRKR

Dyadic International Inc · Marker Therapeutics Inc

DYAI

Dyadic International Inc

MRKR

Marker Therapeutics Inc

Compare $DYAI vs $MRKR

Comparing Dyadic International Inc and Marker Therapeutics Inc

DYAIDyadic International Inc

MRKRMarker Therapeutics Inc

DYAIDyadic International Inc

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.15x

Rev growth (TTM)

-8.1%

YTD performance

-52.8%

52W performance

-60.7%

FCF yield

-45.8%

MRKRMarker Therapeutics Inc

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.16x

Rev growth (TTM)

-46.2%

YTD performance

-36.9%

52W performance

-10.0%

FCF yield

-60.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DYAI

MRKR

Detailed metrics comparison

DYAI

Dyadic International Inc

MRKR

Marker Therapeutics Inc

Market Cap

DYAI$16M

MRKR$16M

Enterprise Value

DYAI$20M

MRKR$5M

Price

DYAI$0.44

MRKR$0.97

P/E Ratio

DYAIN/A

MRKRN/A

P/S Ratio

DYAI4.26x

MRKR6.93x

EV/Sales

DYAI5.21x

MRKR2.08x

EV/EBITDA

DYAI75.44x

MRKR0.00x

P/B Ratio

DYAI14.82x

MRKR1.44x

P/FCF Ratio

DYAIN/A

MRKRN/A

EV/FCF

DYAI-2.67x

MRKR-0.50x

PEG Ratio

DYAIN/A

MRKRN/A

Forward P/E (NTM)

DYAIN/A

MRKRN/A

Forward P/S (NTM)

DYAI2.15x

MRKR3.16x

Revenue (TTM)

DYAI$4M

MRKR$2M

Revenue Growth (YoY)

DYAI-8.1%

MRKR-46.2%

Forward Rev Growth

DYAI91.1%

MRKR375.8%

Gross Margin (TTM)

DYAI16.2%

MRKR0.0%

Operating Margin (TTM)

DYAI0.0%

MRKR0.0%

EBITDA Margin (TTM)

DYAI-194.5%

MRKR-284.3%

Net Margin (TTM)

DYAI-200.5%

MRKR-236.6%

FCF Margin (TTM)

DYAI-194.7%

MRKR-417.6%

Net Income (TTM)

DYAI$-8M

MRKR$-6M

FCF (TTM)

DYAI$-7M

MRKR$-10M

EPS (TTM)

DYAI-$0.21

MRKR-$0.27

ROE (TTM)

DYAI-35086.0%

MRKR-8086.0%

ROA (TTM)

DYAI-8477.0%

MRKR-6705.0%

ROIC (TTM)

DYAI-8444.0%

MRKR-8086.0%

Cash

DYAI$1M

MRKR$11M

Debt

DYAI$5M

MRKR$0

Net Cash/Debt

DYAI$-4M

MRKR$11M

Current Ratio (TTM)

DYAI1.65x

MRKR6.03x

Quick Ratio (TTM)

DYAI1.54x

MRKR5.60x

Debt/Equity (TTM)

DYAI4.08x

MRKR0.00x

Debt/Assets (TTM)

DYAI0.0%

MRKR0.0%

Interest Coverage (TTM)

DYAIN/A

MRKRN/A

Net Debt/EBITDA (TTM)

DYAI0.00x

MRKR0.00x

Beta

DYAI1.09

MRKR1.59

52W Performance

DYAI-60.7%

MRKR-10.0%

YTD Performance

DYAI-52.8%

MRKR-36.9%

% from 52W High

DYAI-72.2%

MRKR-60.5%

% from 52W Low

DYAI30.6%

MRKR15.7%

Asset Turnover (TTM)

DYAI0.42x

MRKR0.20x

FCF Yield (TTM)

DYAI-45.8%

MRKR-60.2%

Earnings Yield (TTM)

DYAI-47.1%

MRKR-34.1%

Dividend Yield (TTM)

DYAIN/A

MRKRN/A

Rule of 40

DYAI-202.8

MRKR-463.8

EV/GP/RG

DYAI0.30

MRKRN/A

Ticker research

View DYAI research View MRKR research

Metric	DYAI Dyadic International Inc	MRKR Marker Therapeutics Inc
Market & Valuation
Market Cap	$16M	$16M
Enterprise Value	$20M	$5M
Price	$0.44	$0.97
P/E Ratio	N/A	N/A
P/S Ratio	4.26x	6.93x
EV/Sales	5.21x	2.08x
EV/EBITDA	75.44x	0.00x
P/B Ratio	14.82x	1.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.67x	-0.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.15x	3.16x
Revenue & Growth
Revenue (TTM)	$4M	$2M
Revenue Growth (YoY)	-8.1%	-46.2%
Forward Rev Growth	91.1%	375.8%
Profitability
Gross Margin (TTM)	16.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-194.5%	-284.3%
Net Margin (TTM)	-200.5%	-236.6%
FCF Margin (TTM)	-194.7%	-417.6%
Net Income (TTM)	$-8M	$-6M
FCF (TTM)	$-7M	$-10M
EPS (TTM)	-$0.21	-$0.27
ROE (TTM)	-35086.0%	-8086.0%
ROA (TTM)	-8477.0%	-6705.0%
ROIC (TTM)	-8444.0%	-8086.0%
Financial Health
Cash	$1M	$11M
Debt	$5M	$0
Net Cash/Debt	$-4M	$11M
Current Ratio (TTM)	1.65x	6.03x
Quick Ratio (TTM)	1.54x	5.60x
Debt/Equity (TTM)	4.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.09	1.59
52W Performance	-60.7%	-10.0%
YTD Performance	-52.8%	-36.9%
% from 52W High	-72.2%	-60.5%
% from 52W Low	30.6%	15.7%
Efficiency & Yields
Asset Turnover (TTM)	0.42x	0.20x
FCF Yield (TTM)	-45.8%	-60.2%
Earnings Yield (TTM)	-47.1%	-34.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-202.8	-463.8
EV/GP/RG	0.30	N/A
Ticker research	View DYAI research	View MRKR research

Valuation

P/S Ratio

DYAI

4.26x

MRKR

6.93x

EV/FCF

DYAI

-2.67x

MRKR

-0.50x

Growth & revenue

Revenue Growth TTM

DYAI

-8.1%

MRKR

-46.2%

Forward Revenue Growth

MRKR

375.8%

DYAI

91.1%

Profitability & performance

Gross Margin

DYAI

16.2%

MRKR

0.0%

ROE

MRKR

-8086.0%

DYAI

-35086.0%

FCF Yield %

DYAI

-45.8%

MRKR

-60.2%

52-Week Performance

MRKR

-10.0%

DYAI

-60.7%

Detailed metrics comparison

DYAI

Dyadic International Inc

MRKR

Marker Therapeutics Inc

Market Cap

DYAI$16M

MRKR$16M

Enterprise Value

DYAI$20M

MRKR$5M

Price

DYAI$0.44

MRKR$0.97

P/E Ratio

DYAIN/A

MRKRN/A

P/S Ratio

DYAI4.26x

MRKR6.93x

EV/Sales

DYAI5.21x

MRKR2.08x

EV/EBITDA

DYAI75.44x

MRKR0.00x

P/B Ratio

DYAI14.82x

MRKR1.44x

P/FCF Ratio

DYAIN/A

MRKRN/A

EV/FCF

DYAI-2.67x

MRKR-0.50x

PEG Ratio

DYAIN/A

MRKRN/A

Forward P/E (NTM)

DYAIN/A

MRKRN/A

Forward P/S (NTM)

DYAI2.15x

MRKR3.16x

Revenue (TTM)

DYAI$4M

MRKR$2M

Revenue Growth (YoY)

DYAI-8.1%

MRKR-46.2%

Forward Rev Growth

DYAI91.1%

MRKR375.8%

Gross Margin (TTM)

DYAI16.2%

MRKR0.0%

Operating Margin (TTM)

DYAI0.0%

MRKR0.0%

EBITDA Margin (TTM)

DYAI-194.5%

MRKR-284.3%

Net Margin (TTM)

DYAI-200.5%

MRKR-236.6%

FCF Margin (TTM)

DYAI-194.7%

MRKR-417.6%

Net Income (TTM)

DYAI$-8M

MRKR$-6M

FCF (TTM)

DYAI$-7M

MRKR$-10M

EPS (TTM)

DYAI-$0.21

MRKR-$0.27

ROE (TTM)

DYAI-35086.0%

MRKR-8086.0%

ROA (TTM)

DYAI-8477.0%

MRKR-6705.0%

ROIC (TTM)

DYAI-8444.0%

MRKR-8086.0%

Cash

DYAI$1M

MRKR$11M

Debt

DYAI$5M

MRKR$0

Net Cash/Debt

DYAI$-4M

MRKR$11M

Current Ratio (TTM)

DYAI1.65x

MRKR6.03x

Quick Ratio (TTM)

DYAI1.54x

MRKR5.60x

Debt/Equity (TTM)

DYAI4.08x

MRKR0.00x

Debt/Assets (TTM)

DYAI0.0%

MRKR0.0%

Interest Coverage (TTM)

DYAIN/A

MRKRN/A

Net Debt/EBITDA (TTM)

DYAI0.00x

MRKR0.00x

Beta

DYAI1.09

MRKR1.59

52W Performance

DYAI-60.7%

MRKR-10.0%

YTD Performance

DYAI-52.8%

MRKR-36.9%

% from 52W High

DYAI-72.2%

MRKR-60.5%

% from 52W Low

DYAI30.6%

MRKR15.7%

Asset Turnover (TTM)

DYAI0.42x

MRKR0.20x

FCF Yield (TTM)

DYAI-45.8%

MRKR-60.2%

Earnings Yield (TTM)

DYAI-47.1%

MRKR-34.1%

Dividend Yield (TTM)

DYAIN/A

MRKRN/A

Rule of 40

DYAI-202.8

MRKR-463.8

EV/GP/RG

DYAI0.30

MRKRN/A

Ticker research

View DYAI research View MRKR research

Metric	DYAI Dyadic International Inc	MRKR Marker Therapeutics Inc
Market & Valuation
Market Cap	$16M	$16M
Enterprise Value	$20M	$5M
Price	$0.44	$0.97
P/E Ratio	N/A	N/A
P/S Ratio	4.26x	6.93x
EV/Sales	5.21x	2.08x
EV/EBITDA	75.44x	0.00x
P/B Ratio	14.82x	1.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.67x	-0.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.15x	3.16x
Revenue & Growth
Revenue (TTM)	$4M	$2M
Revenue Growth (YoY)	-8.1%	-46.2%
Forward Rev Growth	91.1%	375.8%
Profitability
Gross Margin (TTM)	16.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-194.5%	-284.3%
Net Margin (TTM)	-200.5%	-236.6%
FCF Margin (TTM)	-194.7%	-417.6%
Net Income (TTM)	$-8M	$-6M
FCF (TTM)	$-7M	$-10M
EPS (TTM)	-$0.21	-$0.27
ROE (TTM)	-35086.0%	-8086.0%
ROA (TTM)	-8477.0%	-6705.0%
ROIC (TTM)	-8444.0%	-8086.0%
Financial Health
Cash	$1M	$11M
Debt	$5M	$0
Net Cash/Debt	$-4M	$11M
Current Ratio (TTM)	1.65x	6.03x
Quick Ratio (TTM)	1.54x	5.60x
Debt/Equity (TTM)	4.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.09	1.59
52W Performance	-60.7%	-10.0%
YTD Performance	-52.8%	-36.9%
% from 52W High	-72.2%	-60.5%
% from 52W Low	30.6%	15.7%
Efficiency & Yields
Asset Turnover (TTM)	0.42x	0.20x
FCF Yield (TTM)	-45.8%	-60.2%
Earnings Yield (TTM)	-47.1%	-34.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-202.8	-463.8
EV/GP/RG	0.30	N/A
Ticker research	View DYAI research	View MRKR research